The Pharmacological and Medicinal Importance of the Species of Lamiaceae Family, A Review Study
Abstract
The plant of Lamiaceae family is a widely distributed medicinal plant throughout the world and has been used since ancient time. Some examples from this family include mints, thyme, tulsi, spearmint, lavender, sage and rosemary. It is widely cultivated for medicinal, perfumery, culinary and ornamental purposes. Members of this family have been used traditionally as antioxidant, anti cancer, antipyretic, anti-inflammatory, anesthetic, hepatoprotective, anti-diabetic, smooth muscle relaxant, antitumor and for the treatment of wound healing, headache, pains, chronic rheumatism, sedative, gastrointestinal disorders. Phytochemical investigations of the Lamiaceae family have revealed that many components from this family are highly bioactive.The current paper reviews the medicinal properties alongside with bioactive compounds of various plants belonging to the Lamiaceae family. Different compositions like sterols, rosmarinic acid, ursolic acid, menthol, thymol and carvacrol which have been frequently reported from the Lamiaceae family. The current review gives an overview on pharmacological activity and bioactive compounds of different plants of Lamiaceae family, which may be useful for researchers to explore the hidden potential of Lamiaceae family plants and will also help in developing new drugs for the treatment of various diseases.
Full Text:
PDFReferences
Sofowara A. (1982), “Medicinal plants and traditional medicine in Africa”, pp. 6, 10-11, 74, 114.
Rasool Hassan BA (2012), “Medicinal Plants (Importance and Uses)”, Pharmaceut Anal Acta 3: e139. doi:10.4172/2153-2435.1000e139
Batanouny KH, Aboutabl E, Shabana MC, Soliman F (1999), “Wild Medicinal Plants in Egypt: An Inventory to Support Conservation and Sustainable Use”, Academy of Scientific Research & Technology, Cairo, Egypt.
Cragg GM, Newman DJ (2013), “Natural products: a continuing source of novel drug leads”, Biochim.Biophys.Acta, Volume 1830, Issue 6, pp. 3670–3695.
Mukherjee PK, N SK, Heinrich M. (2008), “Plant Made Pharmaceuticals (PMPs) – development of natural health products from bio-diversity”, Indian J. Pharm. Educ. Res. Volume 42, Issue 2, pp. 113–121.
Jardak M, Elloumi-Mseddi J, Aifa S, Mnif S. (2017), “Chemical composition, anti-biofilm activity and potential cytotoxic effect on cancer cells of Rosmarinusofficinalis L. essential oil from Tunisia”, Lipids Health Dis., Volume 16, Issue 1, pp. 190.
Habtemariam S. (2016), “The therapeutic potential of rosemary (Rosmarinusofficinalis) diterpenes for Alzheimer’s disease”, Evid.Based Complement.Alternat.Med., 2680409.
Mendonc¸a-Filho RR. (2006), “Bioactive phytocompounds: new approaches in the phytosciences. In: Modern Phytomedicine: Turning Medicinal Plants into Drugs”, Ahmad I, Aqil F, Owais M (Eds). John Wiley & Sons, Weinheim, Germany, pp. 1–24.
Swain T. (1972), “Plants in the Development of Modern Medicine”, Harvard University Press, Cambridge, Massachusetts.
Heinrich M, Barnes J, Gibbons S, Williamson EM. (2004), “The fundamentals of Pharmacognosy and Phytotheapy”, Churchill Livingstone, Elsevier Science Ltd., London.
O’Neill MJ, Lewis JA. (1993), “Human Medicinal Agents from Plants - Editors Kinghorn AD, Balandrin MF); ACS Symposium Series 534; American Chemical Society, Washington, DC pp. 48−55.
Baker, J.T., Borris, R.P., Carté, B., Cordell, G.A., Soejarto, D.D., Cragg, G.M, Gupta, M.P., Iwu, M.M., Madulid, D.R., Tyler, V.E. (1995), “Natural products drug discovery and development: new perspective on international collaboration”, J. Nat. Prod. Volume 58, Issue 9, pp. 1325−1357.
Ley, S.V., Baxendale, I.R. (2002), “New tool and concepts for modern organic synthesis”, Nat. Rev. Drug Discovery, Volume 1, Issue 8, pp. 573−586.
Geysen, H.M., Schoenen, F., Wagner, D., Wagner, R. (2003), “Combinatorial compound libraries for drug discovery: an ongoing challenge”, Nat. Rev. Drug Discovery, Volume 2, Issue 3, pp. 222−230.
Lombardino, J.G., Lowe III, J.A. (2004), “The role of medicinal chemist in drug discovery- then and now”, Nat. Rev. Drug Discovery, Volume 3, Issue 10, pp. 853−862.
Refbacks
- There are currently no refbacks.